<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>HBOC, on Personal website of Di Shao</title>
    <link>https://dishao.netlify.app/categories/hboc/</link>
    <description>Recent content in HBOC, on Personal website of Di Shao</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <lastBuildDate>Tue, 19 Nov 2019 00:00:00 +0000</lastBuildDate><atom:link href="https://dishao.netlify.app/categories/hboc/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals</title>
      <link>https://dishao.netlify.app/project/hboc/</link>
      <pubDate>Tue, 19 Nov 2019 00:00:00 +0000</pubDate>
      
      <guid>https://dishao.netlify.app/project/hboc/</guid>
      <description>Abstract
background     Identification of deleterious variants in hereditary breast and ovarian cancer (HBOC) susceptibility genes allows for increased clinical surveillance and early detection, and could predict the response to poly (ADP-ribose) polymerase (PARP) inhibitor in patients with advanced ovarian carcinomas.
methods     To determine the prevalence and clinical prediction fac- tors for HBOC syndrome, 882 selected individuals underwent multigene panel testing for HBOC risk assessment during the period from January 2015 to March 2018.</description>
    </item>
    
  </channel>
</rss>
